Trial intelligence / Profile preview

Myo-inositol vs Metformin for Obesity in PCOS

NCT07387679Completed

Start
Nov 2024
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of myo-inositol in obesity (2 arms). Primary endpoint: Body Mass Index at 3 months. Started Nov 2024; status: completed.

02

Drugs

myo-inositol
03

Conditions

obesity

Beyond the preview

Go deeper on NCT07387679.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07387679.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call